Automatic measurement of choroidal thickness was performed in patients after uncomplicated cataract surgery [46], after anti-VEGF injections, in pachychoroid neovasculopathy (PNV) [47], in central serous chorioretinopathy [48], in dry AMD [2], and in parafoveal telangiectasia type 2 [49]. This evidence concerns the gene VEGFA and central serous retinopathy.